APA (7th ed.) Citation

Tsimafeyeu, I., Sultanbaev, A., Dubovichenko, D., Murzalina, M., Volkov, A., Orlova, R., . . . Gluzman, M. Real-world outcomes of lenvatinib plus pembrolizumab in intermediate- and poor-risk metastatic renal cell carcinoma. Open Exploration Publishing Inc.

Chicago Style (17th ed.) Citation

Tsimafeyeu, Ilya, Alexander Sultanbaev, Daria Dubovichenko, Makhabbat Murzalina, Alexander Volkov, Rashida Orlova, Igor Utyashev, Georgy Malina, and Mark Gluzman. Real-world Outcomes of Lenvatinib Plus Pembrolizumab in Intermediate- and Poor-risk Metastatic Renal Cell Carcinoma. Open Exploration Publishing Inc.

MLA (9th ed.) Citation

Tsimafeyeu, Ilya, et al. Real-world Outcomes of Lenvatinib Plus Pembrolizumab in Intermediate- and Poor-risk Metastatic Renal Cell Carcinoma. Open Exploration Publishing Inc.